/

In

VCRO express

VCRO express

Congratulation! VCRO Medical & Technology Consultant Dr. Yu-Chuan Li is elected as president-elect of the IMIA

•

Aug 28
VCRO express

VCRO participates in the first TMU BioMedical Accelerator – Clinical Immersion and Strategy Workshop

•

Jul 9
VCRO express

Congratulations! VCRO obtained a clinical-go from the US FDA to launch the clinical development of a NCE for an orphan disease!

•

Aug 27
VCRO express

Seminar Activities of Clinical Trial in 2018

•

Apr 12
VCRO express

Congratulation! An Orphan Drug Designation (ODD) of autologous immune cell therapy for treating Hepatocellular Carcinoma was granted by the US FDA!

•

Mar 30
VCRO express

Congratulations! Phase I cell therapy for Solid Tumor clinical study report was granted by TFDA!

•

Mar 30
VCRO express

Congratulations! VCRO obtained a permit from the US FDA to launch the clinical development of a NCE in rare disease!

•

Mar 14
VCRO express

Congratulation! Getting the 3 Products of Medical Device Permit License of Class III IOL

•

Feb 13
VCRO express

CRO and CMO form a cross-industry alliance to create a new era of integrative service for new drug development

•

Dec 29
VCRO express

Congratulation! A Phase II IND of the Parkinson’s disease dementia treatment was granted by the US FDA.

•

Nov 21